PE/VC investors

Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.

Investors (6,255)
Investor
Description
More information
Sun Capital Partners Sun Capital Partners
Sun Capital Partners, Inc. is a global private equity firm focused on partnering with outstanding management teams to accelerate value creation. Defensible businesses in growing markets with tangible performance improvement opportunities. $50 million to $1.0 billion in sales for platform investment, any revenue size for add-on opportunities to existing portfolio companies. Industries: Business Services, Consumer, Healthcare, Industrial and Technology.
View
Sun European Partners Sun European Partners
Sun European Partners, LLP is a leading private investment advisory firm, focused on identifying companies'​ untapped potential and leveraging its deep operational and financial resources to transform results. Sun European is a trusted partner that is recognised for its investment and operational experience, including particular expertise in the consumer products and services, food and beverage, industrial, packaging, chemicals, building products, automotive, restaurant and retail sectors. Since 1995, affiliates of Sun European have invested in more than 365 companies worldwide across a broad range of industries and transaction structures. <br />
View
SUN Group Enterprises Pvt. Ltd. SUN Group Enterprises Pvt. Ltd.
SUN Group is a leading principal investor and private equity fund manager in Russia, India and other emerging and transforming markets. The founding shareholders of SUN are part of an Indian family group that has been active in India for more than 100 years and first started working with Russia in 1958. <br /> <br /> The Group has been active in areas such as Aerospace, Oil & Gas, Mining, Real Estate, Infrastructure, Food & Beverage, Technology and Renewable Energy.
View
Sun Hung Kai & Co Sun Hung Kai & Co
Sun Hung Kai & Co. Limited (the “Group”) is an investment firm headquartered in Hong Kong. Since its foundation in 1969, the Group has owned and operated market-leading businesses in financial services. Leveraging on its heritage, experience and network, the Group aims to generate long-term capital growth for its shareholders through a diverse yet complementary portfolio of businesses and investments in multi-asset classes. It is the major shareholder of leading consumer finance firm United Asia Finance, and a substantial shareholder of Everbright Sun Hung Kai The Group currently has about HK$41 billion* in total assets.
View
Sun SEA Capital Sun SEA Capital
Sun SEA Capital is a corporate venture capital established and managed by Sunway Group. Startups will be able to leverage on Sunway’s ecosystem and extensive network to achieve sustainable growth. <br />
View
Sunbo Angel Partners Sunbo Angel Partners
Sunbo Angel Partners (SAP) is a global venture capital firm headquartered in Busan, South Korea, with offices in Ulsan, Gwangju, Seoul, Singapore and Berlin. We strive to provide a platform for open innovation by connecting startups with our corporate alliance of 17 limited partners to create opportunities for business collaboration, joint ventures, co-investment, and merger & acquisition.
View
Sunbridge Partners Sunbridge Partners
SunBridge Partners is all about passion and vision. Passion to make a difference with entrepreneurs, by sharing their vision to change the world. We firmly believe the best way to engage entrepreneurs is to partner with them. Not by sending a check and showing up once a quarter. Not by micromanaging them. Not by parachuting in our favorite CEO to take over. Not by pairing them with a Partner managing 10 other Board seats. <br />
View
Suncorp Group (SUN) Suncorp Group (SUN)
Our purpose is to create a better today for all of our stakeholders; including our customers, shareholders, people and communities. This means we help people live the life they want now and plan for the life they want tomorrow. <br /> <br /> The Group's goal is to create value for our customers through our portfolio of market-leading brands while benefiting from the efficiencies of scale achievable as a large organisation. <br /> <br /> The Group is a diversified, simplified, low-risk financial services group that delivers both high yield and above system growth. Our organic growth strategy is based exclusively in Australia and New Zealand.
View
SunFunder SunFunder
SunFunder is a mission-driven solar finance business based in Nairobi unlocking debt capital for solar energy in emerging markets, where over 2.2 billion people live without access to reliable energy. We offer borrowers a deep solar market expertise, an efficient due diligence process and strong customer partnerships, while simultaneously providing investors with diversified, high-impact, fixed income debt offerings of emerging market solar investments. We have unlocked a total of $62 million for the sector through our Beyond The Grid Solar Fund and other debt facilities. To date we have made over $64 million of loans in 60 debt facilities to 45 solar companies.
View
Sunstone Life Science Ventures Sunstone Life Science Ventures
Sunstone Life Science Ventures is an independent European venture capital investment firm. Our purpose – and passion – is to seek out, enable and empower the most promising life science therapeutics innovations. We help turn new science into new products, improving outcome for patients. And we help create value for innovators, investors and health care systems around the world. We were founded in 2007 by an international team of industry experts combining entrepreneurial, operational and financial experience. This means we have the experience, the competencies and the networks to carefully select and then fully support our portfolio companies with both funding and business development and more. We are committed to working hands-on with our portfolio companies to build value. We work closely with management and board members and also offer the competencies of our experienced Business Development Board. This board consists of leading international Life Science executives who have all been involved hands-on in licensing, partnerships and M&A’s on the buy-side. We believe that the founder/investor relationship works best when built on a balanced foundation of respect and honesty. Building a successful start-up is rarely a straightforward process, and most companies experience troubles at some point in time. In that situation, everyone is best served by having an honest and collaborative relationship. Sunstone Life Science Ventures focuses on investment opportunities based on novel therapeutics for humans; with strong potential for global success. We typically make our initial investment in companies raising Series A or B rounds, but in some cases even earlier. See more in our Investment Strategy To date, Sunstone Life Science Ventures has invested in more than 45 life science companies and several successful IPOs and large M&A transactions have been completed from our portfolio so far (see below). The road from innovation to market in the life sciences area often demands both large-scale and long-term investments. Accordingly, we more often than not co-invest with other funds and institutional investors. We encourage and welcome both (co-) investors and innovators to contact us to open a dialogue. Investment Strategy & Management Sunstone Life Science Ventures invests in early-stage life science companies developing novel therapeutics for humans. Our geographical scope is Europe including UK with particular emphasis on the European life science hubs. Our point of entry differs depending on the type of opportunity; however, we usually invest when drug candidates are in the pre-clinical or clinical phase I. Sunstone Life Science Ventures’ investment strategy has a strong industry focus vis-à-vis potential buyers of our portfolio companies. Since we believe that most exits in the life science sector will continue to take place in the M&A space, we prefer business models suitable for this exit route. To appear on the radar of potential acquirers, we invest in opportunities that truly stand out in terms of both science and market positioning. We seek opportunities which target unmet medical needs in commercially attractive markets, and we seek products which, once approved, are likely to receive attractive reimbursement and pricing structures. We have a preference for companies targeting niche markets. Opportunities aimed at specialty pharma and orphan drug indications are especially interesting to us, and oncology continues to be an important area, for society and for investors alike. We believe that the single most important factor when developing a successful company is the quality of the management team. This does not mean that we only invest in savvy entrepreneurs with a strong track record. But less experienced management teams should be open to change if needed to accelerate the company. We are committed to working hands-on with our portfolio companies to build value. In order to do so, Sunstone is represented on the board of directors and works closely with the management team and the other board members to develop the company. As an extra, unique offering, aimed at building the value of our portfolio companies, we offer access to Sunstone’s Business Development Board, established in 2007 and consisting of leading Life Science executives who have all been involved hands-on in licensing, partnerships and M&A’s on the buy-side. Sunstone Life Science Ventures Fund I was established at the inception of Sunstone in 2007. The total committed capital is EUR 200 million. The investment strategy included therapeutics, medical technology and diagnostics. The fund is no longer making new investments. Sunstone Life Science Ventures Fund II was established at the inception of Sunstone in 2007. The total committed capital is EUR 86 million and the fund invested in 12 new portfolio companies. The investment strategy included therapeutics, medical technology and diagnostics. The fund is no longer making new investments. In 2010, Sunstone took over management of the former BankInvest Biotechnology Funds. The funds are no longer making new investments. Sunstone Life Science Ventures Fund III was established in 2012. The total committed capital is EUR 80 million and the fund invested in 11 new portfolio companies. The investment strategy included therapeutics, and medical technology. The fund is no longer making new investments. Sunstone Life Science Ventures Fund IV was established in 2019. The total committed capital is EUR 92 million. The investment strategy is focused entirely on therapeutics. The fund is currently building the portfolio and is actively pursuing new investment opportunities.
View

Investor Database: Find Angel Investors, VCs & Private Equity Firms

Find angel investors, venture capital firms, and private equity investors worldwide.

Search thousands of active investors by stage, industry, and location. Built for founders, fundraising teams, and M&A advisors who need relevant investors fast.

Database at a Glance

  • 6,000+ investors
  • 111 countries covered
  • Angels, venture capital, and private equity in one platform
  • Filter by stage, industry, and location

A Searchable Directory of Active Investors

This is a global investor database built for fast, targeted discovery.

Instead of spreadsheets or generic lists, you can search verified angel investors, venture capital firms, and private equity funds actively investing across markets, industries, and stages.

Everything is structured to help you identify relevant investors quickly and move straight to outreach.

Private Equity List’s AI Search tool lets you describe your company or deal and returns investors with matching investment history, so you are not guessing who might be a fit.

Investor Database With Actionable Data

Every profile is designed to help you assess fit without unnecessary digging.

Each investor profile includes:

  • Investor or firm name
  • Investor type (Angel, Venture Capital, Private Equity)
  • Country and geographic focus
  • Investment stage preference
  • Industry and sector focus

This allows you to shortlist investors based on real criteria, not assumptions.

Global Coverage Across Angels, VC, and Private Equity

The directory supports fundraising and deal sourcing across regions and investor types.

  • Thousands of investors listed worldwide
  • Coverage across multiple countries
  • Angel investors, VC firms, and PE funds in one place
  • Continuously expanding investor coverage

Whether you’re raising early-stage capital or sourcing institutional investors, the database scales with your needs.

Filter Investors by Stage, Industry, and Location

Finding the right investors shouldn’t require manual sorting.

You can filter investors by:

  • Investor type (Angel, VC, Private Equity)
  • Industry and sector
  • Investment stage
  • Country and location

These filters help you focus only on investors aligned with your raise or transaction.

Built for Founders, Fundraising Teams, and Advisors

This investor database is designed for people actively sourcing capital or investors.

Startup Founders

Find investors aligned with your stage, sector, and geography. Build targeted investor lists and reduce time spent on cold outreach.

Fundraising and Growth Teams

Accelerate investor research, improve targeting, and support active fundraising with structured data.

M&A Advisors and Dealmakers

Identify investors and capital partners across regions and deal types. Source active capital faster with better precision.

Search, Shortlist, and Start Outreach

Using the database is straightforward and built for speed.

  1. Search investors using filters for stage, industry, and location
  2. Build a targeted investor shortlist
  3. Begin outreach or deal sourcing

Start Searching Investors Today

Access a global database of angel investors, venture capital firms, and private equity funds built for high-intent fundraising.

Our AI Search tool helps you quickly identify the most relevant investors based on stage, sector, geography, and real investment behaviour.

Search Investors

FAQs

An investor database typically includes structured investment data such as investor type, geographic focus, preferred investment stage, and industry or sector interests.
Yes, most comprehensive investor databases include angel investors alongside venture capital firms, private equity funds, and other early-stage investment sources.
The insight provided depends on how frequently the database is updated, but profiles generally reflect publicly available information on investment focus, stage, and location.
Yes, many investor databases include family office investors, allowing users to identify them by location, investment focus, and deal type.
Investor databases are commonly used by startup founders, fundraising teams, and advisors who need a structured way to research and identify relevant investors.